Poster List

Poster Session 1 (14 Oct 2025) — Posters 1 to 56

Poster Session 2 (15 Oct 2025) — Posters 57 to 112

Poster Number Title Presenting Author
1 Genome-wide CRISPR screen identifies EIF4H and YBX1 as essential host factors for HEV replication Qiang Ding
2 Blood-Brain Barrier Disruption and NS1-Mediated Pathogenesis in Tick-Borne Encephalitis Virus Infection Martin Palus
3 Dynamic Profiling of Flaviviral Infection and Replication Dynamics with Host Responses Using Real-Time Bioluminescence Masahiko Ito
4 Synthesis and biochemical evaluation of non-structural polyprotein of Flaviviridae using a wheat cell-free system with nanodisc technology Hirotaka Takahashi
5 AlphaFold3-Enabled Discovery of Early Infection Antibody Targets in an HCV Super Clearer Ahmed Abdul Quadeer
6 Roles of rodent orthologues of HCV entry factors in NRHV1 infection Tomohisa Tanaka
7 Between- and within-host mutation of dengue virus Sachith Wijethunga Arachchige
8 Dengue virus infection reprograms baseline innate immune gene expression Ong Ziying Eugenia
9 An integrated proteomic approach identifies a conserved and non-canonical role for UFMylation in orthoflavivirus replication Sreejith Rajasekharan
10 Interferon-independent host factors define the hepatitis E virus species barrier in murine hepatocytes Nicola Frericks
11 Interferon-induced immune signatures are associated with suppression of HEV infection in porcine cell culture models Nicola Frericks
12 Hepatitis E virus entry requires the cholesterol transporter Niemann-Pick C1 Nicola Frericks
13 Applying sequence projection and k-means as novel approach for Orthohepevirinae genotyping and species assignment Daniel Todt
14 The road towards a decision support tool for Hepatitis E virus treatment failure and chronicity Daniel Todt
15 Replication assessment of chimeric HEV-3 subtypes demonstrate enhanced replication fitness of HEV-3f isolates Rui Pedro Marques da Costa
16 Application of Chimeric Binjari virus Antigens to Paper-based Diagnostics for Detecting Orthoflaviviral Infections in the Veterinary Field Jody Peters
17 A Reverse Genetics Approach with Circular Polymerase Extension Reaction (CPER) for Rapid Generation of Insect-Specific Flaviviruses to Study Superinfection Exclusion Chan Jia Xiang Justin
18 HCV replication fitness as a potential contributor to failure of direct acting antiviral therapy Paul Rothhaar
19 Development and characterization of a novel T-cell-targeting hepatitis C virus vaccination strategy Lucija Bujanic
20 Iterative Genetic Humanization of Mice Reveals Barriers to Hepatitis C Virus Infection Despite Permissive Host Factor Engineering Sreya Sanyal
21 Structural characterisation of anti-JEV human antibody epitopes reveals a new target for broad spectrum therapies and vaccines. Connor Scott
22 Construction of novel adenoviral vaccine vectors and the application in the development of HCV vaccines Tingting Li
23 Investigating the pathogenesis of neurotropic orthoflaviviruses with cerebral organoids Ku Wei Kay Joanne
24 Germline-targeting Hepatitis C Virus Immunogens with broad affinity for precursors of AR3C-Class Broadly Neutralizing Antibodies Dieter Hoffmann
25 The significance of high GC content in hepatitis C virus genomes Saori Suzuki
26 Amino acid changes in two viral proteins drive attenuation of the yellow fever 17D vaccine Melina Winkler
27 Discovery of Dual Therapeutics Targeting Both HCV Replication and HCC Progression Using Patient-Derived Liver Organoids Geonwoo Kim
28 Beyond Storage: Lipid droplets as novel extracellular communicators in flavivirus infection Irumi Amarasinghe
29 Zika virus induces altered microglial expression of surface receptors involved in CD8+ T cell activation Karolina Bentkowska
30 Optimising pan-genotypic T-cell vaccine strategies against hepatitis C virus: a comparative analysis of homologous vs heterologous prime-boost regimens Rebecca Strain
31 DENV NS1 disrupts pericyte-endothelial cell signalling to amplify dengue vascular leakage Justin Duruanyanwu
32 Using alternative lectins for a lectin capture ELISA to detect HCV antibodies. Julie Sheldon
33 Host genetics shapes cytosine and uracil composition of the HCV genome Yan Chen
34 Variation in Phenotype and Genotype of Circulating Powassan Virus Isolates Saravanan Thangamani
35 Functional and Phenotypic Profiling of HCV-Specific CD8+ T Cells Across Acute, Chronic, and Spontaneous Resolvers of Infection Ayoub Mahassine
36 Immunomodulation at the feeding site during Powassan virus transmission from Ixodes scapularis ticks Dakota Paine
37 TNF inhibition is uniquely effective as an anti-inflammatory treatment for Dengue infection in mice William Clow
38 Establishment of the recombinant rodent hepacivirus with HiBiT gene. Yasunori Akaike
39 GC Content Optimization of Reporter Genes Determines Stability of Recombinant +ssRNA Viruses Tomokazu Tamura
40 The cooperation of Flaviviral Subgenomic RNA (sfRNA) and non-structural protein 5 (NS5) for antagonism of host innate immune response Jarvis Goh
41 Analysis of the mechanism of blood-brain barrier disruption during Japanese encephalitis virus infection Tatsuya Suzuki
42 Mast cells promote protective immune memory recall during secondary dengue infection. Chinmay Kumar Mantri
43 Mast cell contributions to B cell function and antibody responses Wilfried Alexandre Alexis Saron
44 Mapping of the Tick-Borne Encephalitis Virus RNA interactome identifies specific interactions with the small nuclear RNA, U1 Emma Alberte Lundsgaard
45 Design and non-viral delivery of live attenuated vaccine to prevent chronic hepatitis C virus-like infection. Peter Simmonds
46 Immunogenicity of Hepatitis E Virus Nucleic Acid Vaccines Expressing ORF2 Riko Yoshida
47 Structural Insights into Dengue Virus NS1 Oligomerization and Heparan Sulfate Engagement in Endothelial Hyperpermeability Qunfei Zhou
48 Acquisition of Four Amino Acid Substitutions Promotes Robust Replication of Hepatitis C Virus Genotype 1b in Cell Culture Noriyuki Watanabe
49 Norway rat hepacivirus envelope glycoprotein confers protective immunity as a novel surrogate vaccine approach for HCV Andreas Kok
50 Pathogenic Dengue Virus TW2015 strain Infection Triggers Anaerobic Glycolysis and Enhances Mortality in Diabetic Mice Guann-Yi Yu
51 Distinct patterns of nucleotide composition across Hepatitis C Virus genotypes reveal host-virus co-evolutionary signals Sofya Lebedeva
52 N153-linked glycans on the envelope protein of orthoflaviviruses antagonize antibody-mediated host defenses Donald Ting Heng Rong
53 Thapsigargin modulates lipid droplets and inhibits hepatitis C virus infection Trinity Tooley-Macarandang
54 ZIKV NS5-Mediated STAT2 Degradation as a Determinant of Immune Evasion and Pathogenicity Yuzhang
55 Development of a novel recombinant subunit vaccine candidate against Zika virus Manjima Das
56 CRISPR Activation of Interferon Stimulated Genes: Dual Approaches to Screening for Antiviral Effects against Orthoflaviviruses Xavier Montin
57 Live cell imaging of the biogenesis, localization and traffic of dengue virus NS1 protein puncta during a productive infection Nicholas Eyre
58 Development of mRNA vaccines for Hepatitis C virus Joey Mcgregor
59 Profiling HCV vaccine-induced antibody responses with E2 epitope knockout (Eko) probes Xander Wilcox
60 Unraveling HCV Diversity and Resistance in Vietnam: Implications for Treatment Chau Le Ngoc
61 The interferon and interferon-stimulated gene response of the first trimester placenta to Zika virus infection. Kylie Van der Hoek
62 Development of an immunogenic single-dose live attenuated ZIKV vaccine using an orthoflavivirus genome recoding platform Chin Wei Xin
63 Lost in translation: Flavivirus infection and the production of tRNA halves Rhys Parry
64 Evaluating Usutu virus infection dynamics and potential therapeutics using a fluorescent reporter Amy Nelson
65 Specialized RNA Secondary Structures of Avian Flavivirus 3'UTR Regulate Viral Avian Host shifting Shun Chen
66 Multi-Antigen DNA Vaccine Induces Potent T Cell Protection Against Zika Virus Ryan Santos
67 Building a complex understanding of dengue microvascular dysfunction through novel in vitro 3D multicellular systems Kevin Maringer
68 A Rare HCV E2 Antibody That Defies the Classic Easy- and Hard-to-Neutralize Divide Filip Popovic
69 Powassan virus induces sex-specific neurological disease and long-lasting sequelae in C57BL/6Ntac mice Devin Kenney
70 Nur77 Modulates HCV Replication Through Interaction with NS5B RNA polymerase Ju-Chien Cheng
71 ISVac Chimeric Vaccines: From Veterinary Efficacy to Advancements for Human Application Jody Peters
72 Age-stratified immune responses reveal distinct mechanisms underlying dengue resolution and severe disease progression Veronica Duran
73 Yellow fever vaccine propagation in primary human hepatocytes triggers antiviral and cytolytic responses Daniel Todt
74 Host cell factors control whether pestiviruses depend on micro-RNAs for replication Rui Pedro Marques da Costa
75 Development of a Novel HCV Genotype 4r Subgenomic Replicon Reveals Intrinsic Resistance to Sofosbuvir Jin Zhong
76 Engineered Molecular Warheads Selectively Target Virus-Infected Mosquito Cells Yu-Ning Huang
77 Structural stabilization of Hepatitis C Virus E2 protein 412-423 antigenic region guides the humoral immune response towards an AP33 mAb like idiotype Lia Cucos
78 Mast cells promote antigen specific T cell responses during dengue virus infection Ma Haiyan
79 Gold(I) Complexes are active compounds against flavivirus Antonio Mas
80 HCV evades innate immune-mediated translational shutdown through RNA non-canonical capping Lizandro René Rivera Rangel
81 Induction of HCV-specific Antibodies and T cells targeting multiple HCV genotypes through the co-administration of rationally designed vaccine antigens in mRNA/LNP Gerardo Montalvo Zurbia-Flores
82 Insulin signaling regulates cellular resistance to HCV entry by triggering the endo-recycling trafficking machinery Makoto Nagano
83 Novel Tick-borne encephalitis virus nano-luciferase neutralization assay Lev Levanov
84 Inhibition of dengue replication by marine natural products Sarin Chimnaronk
85 Role of an AH/BAR domain superfamily protein on HCV assembly Ayaka Kimura
86 Investigating the role of lipids in Zika virus-induced ER remodelling Alina Nadine Rosinski
87 Characterization of yellow fever virus resistance to sofosbuvir and uprifosbuvir in cell culture Alekxander Binderup
88 Substitutions in the NS5 of tick-borne encephalitis virus confer high resistance to remdesivir Itsaso Ortigosa Elorz
89 Toll-like receptor 4 restricts dengue virus infection in a macrophage cell model Che Colpitts
90 Identification of Novel Zika Virus Protease Substrates in Mammalian Cells Using N-Terminomics Jessica Coomber
91 Peptide Trimming by ERAP1 Allotypes Modulates HLA-A*01:01-Mediated Immune Recognition of HCV Qijing Shen
92 Exploiting the Clec9A targeting vaccine platform to develop a safe and effective DENV vaccine Geraldine Nadya Putri
93 Occult hepatitis C virus infection (OCI) in patients with sustained virologic response (SVR) Haruyo Aoyagi
94 Neutralization sensitivity of HCV genotype 3b Core-NS2 recombinant viruses in vitro and in vivo. Jens Bukh
95 Efficacy of inhibitors Velpatasvir and Pibrentasvir in human-liver chimeric mice infected with hepatitis C virus subtype l of genotype 1 carrying inherent NS5A inhibitor-resistant substitution. Laura Collignon
96 Mechanism of action of the antiviral bacterium, Wolbachia, against dengue virus. Robson K. Loterio
97 HCV E1E2 stabilization and nanoparticle optimization for vaccine development Gilad Ofek
98 Rapid whole-blood analysis of dengue-specific T cell responses reveals long-term immune memory and informs infection history Nina Le Bert
99 Selective Regulation of Human Endogenous Retroviruses in Liver Cirrhosis and Hepatitis Virus Infection Emanuele Marchi
100 Broadly Neutralizing Antibody Responses in Mice Induced by an Inactivated HCV vaccine Produced by a Novel Scalable Bioprocess Carlos Rene Duarte Hernandez
101 Development of a recombinant vaccinia virus for the Hepatitis C virus NS protein aimed at immunotherapy through a Heterologous Region Prime/Boost vaccine Kyoko Kohara
102 Heterologous prime/boost HCV vaccine expressing VLPs and non-structural proteins induces a broad and polyfunctional T cell response in rhesus macaques Rama Amara
103 The two-step purification method ViREn identifies a single NSUN6-mediated 5-methylcytosine modification promoting dengue virus RNA genome turnover Chia Ching Wu
104 Tick-borne encephalitis virus and its NS1 protein alter endothelial monolayer integrity and structure Monika Cizkova
105 Dengue virus serotype 2 lacking N153 glycosylation exhibited structural stability and increased recognition by neutralizing antibodies Guntur Fibriansah
106 Characterizing resistance profiles for HCV in Pakistan Meghna Tripathi
107 Identification of RNA processing machinery as druggable host factor targets for dengue virus infection Min Jie Alvin Tan
108 Structural and Antigenic Diversity of Emerging Japanese Encephalitis Virus Genotypes Naphak Modhiran
109 Zika Virus Targets Suture Stem Cells to Drive Craniofacial Abnormalities Weiqiang Chen
110 Immune dynamics of maternal peripheral blood and placenta to Yellow Fever vaccine during pregnancy Suan-Sin Foo
111 TMessenger RNA Vaccines Targeting Non-Structural Proteins are Highly Protective Against Dengue Virus Infection in Mice Satoru Watanabe
112 Understanding the functional contributions of brain-specific viral variants in Zika Virus pathogenesis Chan Wing Ki Kitti